QA: Entrada Therapeutics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001689375_2023_Entrada_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001689375, Entrada Therapeutics Inc.

  xvar xval
0 AssetsCurrent 209,875,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,681,000
3 remainder_Assets 34,500,000
4 LiabilitiesCurrent 21,972,000
5 LiabilitiesNoncurrent 17,530,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 30,639,000
9 ResearchAndDevelopmentExpense 66,609,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,632,000
13 remainder_ComprehensiveNetIncome -2,057,000
  yvar yval
0 Assets 252,056,000
1 Liabilities 39,502,000
2 Expenses 97,248,000
3 Revenues 0
4 StockholdersEquity 212,554,000
5 NetIncome -94,616,000
6 ComprehensiveNetIncome -95,644,500
7 BaseVar 196,747,500
8 EconomicCapitalRatio 1.85

Edgar->Model Mapping

Feature Distribution

Change over Time